In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Cardio-Oncology: Novel mechanisms and clinical implications
Session

Congress : ESC Congress 2019

Topic : Cardiac Diseases, Other

  • Session type : Symposium
  • Date : 01 September 2019
  • Time : 11:00 - 12:30

4 presentations in this session

The failing heart stimulates tumor growth by circulating factors

Congress : ESC Congress 2019

  • Session : Cardio-Oncology: Novel mechanisms and clinical implications
  • Speaker : R De Boer (Groningen,NL)

Inflammation as a common risk factor for cancer and cardiovascular disease.

Congress : ESC Congress 2019

  • Session : Cardio-Oncology: Novel mechanisms and clinical implications
  • Speaker : P Libby (Boston,US)

Cardiovascular side effects of anti-tumor drugs.

Congress : ESC Congress 2019

  • Session : Cardio-Oncology: Novel mechanisms and clinical implications
  • Speaker : J Moslehi (Nashville,US)

Mechanisms and models of anti-cancer drugs.

Congress : ESC Congress 2019

  • Session : Cardio-Oncology: Novel mechanisms and clinical implications
  • Speaker : A Ghigo (Turin,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are